Company Overview

HempFusion Wellness Inc. is a health and wellness company focused on hemp-derived cannabidiol (CBD) products and complementary nutraceutical offerings. The company has operated within the broader consumer wellness, dietary supplement, and cannabinoid sectors, developing products marketed for sleep, stress support, pain management, and overall wellness. HempFusion historically generated revenue through retail distribution, direct-to-consumer e-commerce, and white-label or affiliated wellness channels. Its portfolio has included tinctures, capsules, topical products, gummies, and probiotic supplements under brands such as HempFusion, Probulin Probiotics, and Biome Research.

The company was founded in 2015 and pursued rapid expansion during the growth phase of the North American CBD market following evolving U.S. hemp regulations, including the 2018 Farm Bill. HempFusion became publicly traded in Canada and later quoted in U.S. over-the-counter markets under the ticker CBDHF. Public filings and market disclosures indicate the company sought differentiation through regulatory-focused manufacturing standards, physician and practitioner outreach, and broad retail placement across natural food, pharmacy, and wellness channels. Public disclosures from later periods also reflected financial pressures affecting the broader CBD industry, including pricing compression, regulatory uncertainty, and capital market constraints.

Business Operations

HempFusion’s operations historically centered around branded wellness products and nutraceutical distribution. The company’s primary operating activities included formulation, manufacturing oversight, product marketing, and retail distribution of hemp-derived CBD products and digestive health supplements. Through brands including HempFusion, Probulin Probiotics, and Biomes Research, the company targeted consumers seeking natural wellness solutions as well as healthcare practitioners and specialty retailers. Revenue was primarily derived from product sales through e-commerce platforms, health and wellness stores, pharmacy channels, and select international distributors.

The company operated principally in the United States while maintaining exposure to international wellness markets through distribution partnerships and cross-border sales initiatives. HempFusion previously emphasized vertically integrated sourcing and manufacturing controls intended to support product consistency and regulatory compliance. Public company disclosures also referenced relationships with retailers and wellness-focused distribution networks. Available filings indicate the company invested in formulation development, quality testing, and regulatory compliance capabilities as part of its operating strategy. Data regarding the current operational scale and active business units is limited in recent public disclosures, and some operational information is inconclusive based on available public sources.

Strategic Position & Investments

HempFusion’s strategic direction focused on expanding branded wellness products in the CBD and nutraceutical sectors while positioning itself as a compliance-oriented operator in a fragmented industry. Growth initiatives historically included expanding retail distribution, increasing direct-to-consumer sales, broadening practitioner-channel relationships, and developing additional wellness formulations. The company also pursued brand diversification through acquisitions and portfolio expansion in digestive health and probiotic categories.

A notable strategic transaction included the acquisition of Apothecanna, a topical CBD and body-care brand, which broadened the company’s personal care product offerings. HempFusion also maintained ownership interests in brands such as Probulin Probiotics and Biome Research, reflecting efforts to diversify beyond CBD-only exposure into broader health and wellness categories. Public filings and investor materials referenced initiatives tied to product innovation, regulatory readiness, and international expansion opportunities. However, financial disclosures in subsequent reporting periods indicated liquidity challenges and broader industry headwinds affecting growth execution. Information regarding ongoing investment activity or current acquisition strategy remains limited in publicly available recent filings.

Geographic Footprint

HempFusion’s headquarters were located in Denver, Colorado, and the company’s primary commercial operations were concentrated in the United States. The company distributed products across multiple U.S. retail channels, including health food stores, natural product retailers, practitioner networks, and e-commerce platforms. Public disclosures also referenced expansion initiatives in Canada, Europe, and select international wellness markets, although the majority of historical revenue appears to have originated from the U.S. market.

The company’s international presence was comparatively smaller than its domestic footprint but included distribution arrangements and market development activities tied to evolving global CBD regulations. HempFusion publicly highlighted opportunities in regions where hemp-derived wellness products and nutraceuticals were gaining regulatory acceptance. Available public records do not provide comprehensive recent confirmation regarding the company’s current international operational scale, and some geographic operating data is inconclusive based on available public sources.

Leadership & Governance

HempFusion was founded by wellness industry entrepreneurs and executives with experience in nutraceuticals, natural health products, and consumer packaged goods. The company’s leadership strategy emphasized regulated wellness manufacturing, physician-oriented education, and mainstream retail distribution. Public company materials and governance disclosures indicated a focus on building consumer trust through product testing, compliance standards, and diversified wellness branding.

Key executives and leadership figures identified in public filings and company disclosures have included:

• Jason Mitchell – Co-Founder and former Chief Executive Officer
• Jason Cranmer – Co-Founder and former Chief Executive Officer of Probulin Probiotics
• Maria Stipp – Former Chief Executive Officer
• Kevin Harrington – Strategic advisor and board affiliate in certain public company materials
• Dr. Michael Lewis – Medical and scientific advisory contributor associated with wellness initiatives

Leadership and governance details have varied over time due to executive transitions and corporate restructuring activities reflected in public filings. Recent governance information for the company is limited, and certain executive role statuses are inconclusive based on available public sources.